ANTHEM-TIMI 32 assessed the efficacy and safety of anticoagulation with rNAPc2 in non-ST segment elevation acute coronary syndrome patients managed with an early invasive strategy.
An Academic Research Organization of Brigham & Women's Hospital and An Affiliate of Harvard Medical School
